What is Johnson & Johnson (JNJ)?

Johnson & Johnson (JNJ) is a stock in the Healthcare sector, Drug Manufacturers - General industry. View full analysis on Stocks360.

What is the current price of JNJ?

The current price of JNJ is $272.26. Prices are updated in real time on Stocks360.

What is JNJ's price-to-earnings (PE) ratio?

JNJ's trailing twelve-month PE ratio is 41.28, based on current price and earnings per share data available on Stocks360.

What is JNJ's market capitalization?

JNJ's market capitalization is $655,414,298,739.00, placing it in the large-cap tier.

Does JNJ pay a dividend?

Yes. JNJ has a trailing twelve-month dividend yield of 0.02%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Johnson & Johnson (JNJ)

Stock analysis · NYSE · Healthcare · Drug Manufacturers - General

$272.26

Market Cap

$655.41B

PE (TTM)

41.28

EPS (TTM)

N/A

Dividend Yield

1.94%

Beta

0.23

Day Range

$264.20 – $272.35

52-wk Range

$184.66 – $281.07

Avg Volume

N/A

Volume

1.20M

Johnson & Johnson (JNJ) is a publicly traded company in the Healthcare sector. Latest price: $272.26. Market cap $655.41B. Trailing PE 41.28. Dividend yield 1.94%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $186.93 2026-10-28 · $272.04 (+45.53%)

Earnings

Most Recent

Oct 13, 2026

EPS $2.59 vs est. $2.52

Beat by $0.07

Next Earnings

Jan 20, 2027

EPS estimate $2.91

Proprietary Signals

Signal snapshot temporarily unavailable.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	41.28×
P/S (TTM)	6.60×
P/B	8.17×
P/FCF (TTM)	31.83×
EV / EBITDA	22.17×
EV / Sales	6.88×
Earnings Yield	2.42%
Free Cash Flow Yield	3.14%
Dividend Yield	1.94%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$683.16B
Revenue (TTM)	$99.33B
Net Income (TTM)	$15.83B
Free Cash Flow (TTM)	$21.31B
Net Debt	$27.74B
Working Capital	$894.00M
Gross Margin	68.81%
Operating Margin	25.70%
Net Margin	16.20%
Return on Equity	19.55%
Return on Invested Capital	15.36%